Frontlight ResearchEarly access
Hepatitis B trials in China
65 of 106 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
- Where
- Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming, Shenzhen, Wuhan, Zunyi
- Age
- 18 years to 65 years
- People
- 200
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07069569 - Phase 1Taking peopleA Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
- Where
- Chengdu, Chongqing, Hangzhou, Shanghai, Zhengzhou
- Age
- 18 years to 65 years
- People
- 32
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07600788 - Phase 2Taking peopleA Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jiangmen, Kunming, Liuzhou, Meizhou, Nanchang, Nanjing, Qingyuan, Shanghai, Shenyang, Shenzhen, Wuhan, Xiamen, Xi’an, Yichang
- Age
- 18 years to 65 years
- People
- 320
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07635186 - Phase 1Taking peopleA Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
- Where
- Ch’ang-ch’un, Hangzhou
- Age
- 18 years to 65 years
- People
- 110
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07511218 - Phase 2Taking peopleStudy of AHB-171 in Chronic Hepatitis B Participants
- Where
- Beijing, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jilin City, Nanning, Xiamen, Zhengzhou
- Age
- 18 years to 65 years
- People
- 138
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07630727 - Phase 2Taking peopleStudy of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
- Where
- Beijing
- Age
- 35 years to 65 years
- People
- 80
- Run by
- Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07709520 - Phase 1Taking peopleA Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
- Where
- Chengdu
- Age
- 18 years to 65 years
- People
- 9
- Run by
- Jiyan Liu
See details and how to joinNCT07051187 - Phase 4Enrolling by invitationTAF in Early/Middle Pregnancy With CHB
- Where
- Guangzhou
- Age
- 20 years to 40 years
- People
- 816
- Run by
- The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07668934 - Phase 2Taking peopleClinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
- Where
- Chongqing
- Age
- 18 years to 45 years
- People
- 45
- Run by
- Huahui Health
See details and how to joinNCT07519330 - Early phase 1Not yet taking people in ChinaEfficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
- Where
- Hangzhou, Ningbo
- Age
- 18 years to 65 years
- People
- 156
- Run by
- Ningbo No.2 Hospital
See details and how to joinNCT07553767 - Phase 1Taking peoplehUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
- Where
- Changsha
- Age
- 18 years to 60 years
- People
- 20
- Run by
- Sclnow Biotechnology Co., Ltd.
See details and how to joinNCT03826433 - No phaseNot yet taking people in ChinaUnion-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients
- Where
- Wuhan
- Age
- 18 years and over
- People
- 2,000
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07520123 - Phase 3Not yet taking people in ChinaA Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 1,208
- Run by
- Beijing Continent Pharmaceutical Co, Ltd.
See details and how to joinNCT07412236 - Phase 1/2Taking peopleClinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Beijing Tuohua Weiye Biotechnology Co., Ltd.
See details and how to joinNCT07413549 - Phase 3Taking peopleTo Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 526
- Run by
- Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07090759 - Early phase 1Taking peopleImmunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
- Where
- Beijing
- Age
- 18 years to 60 years
- People
- 132
- Run by
- Peking University People's Hospital
See details and how to joinNCT07328711 - Phase 3Taking peopleA Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
- Where
- Zhengzhou
- Age
- 18 years to 65 years
- People
- 120
- Run by
- Zhigang Ren
See details and how to joinNCT07307586 - Phase 1Taking peopleSA1211 Injection Phase 1 Study
- Where
- Changchun
- Age
- 18 years to 65 years
- People
- 80
- Run by
- Suzhou Siran Biotechnology Co.,Ltd.
See details and how to joinNCT07275918 - Phase 2Taking peopleA Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 369
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT06425341 - Phase 4Not yet taking people in ChinaProspective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B
- Where
- Guangzhou
- Age
- 3 years to 18 years
- People
- 113
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07231276 - Phase 4Taking peopleStudy of Tenofovir Alafenamide in HBV-Infected Pregnant Women
- Where
- Hangzhou
- Age
- 20 years to 40 years
- People
- 50
- Run by
- First People's Hospital of Hangzhou
See details and how to joinNCT05853718 - Phase 3Not yet taking people in ChinaA Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB
- Where
- Changchun
- Age
- 18 years to 65 years
- People
- 1,300
- Run by
- Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT07095855 - Phase 1Taking peopleHBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 19
- Run by
- Changhai Hospital
See details and how to joinNCT06885710 - Phase 3Taking peopleHydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
- Where
- Beijing, Bengbu, Changsha, Chongqing, Guizhou, Hangzhou, Henan, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Shenzhen, Xinxiang, Yanbian, Zhenjiang, Zunyi
- Age
- 18 years to 65 years
- People
- 248
- Run by
- Beijing Continent Pharmaceutical Co, Ltd.
See details and how to joinNCT05905172 - Phase 3Taking peopleProphylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 136
- Run by
- Sun Yat-sen University
See details and how to joinNCT06966232